Treatment of Neuroendocrine Tumor Liver Metastases

by Lewis, Mark A., Hobday, Timothy J.
Published 2012

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

by Walia, Tamana, Quevedo, J Fernando, Hobday, Timothy J, Croghan, Gary, Jatoi, Aminah
Published 2008

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

by Starr, Jason S, Sonbol, Mohamad Bassam, Hobday, Timothy J, Sharma, Akash, Kendi, Ayse Tuba, Halfdanarson, Thorvardur R
Published in Onco Targets Ther (2020)

Dose Modification for Safe Treatment of a Compound Complex Heterozygous DPYD Variant Carrier With Fluorouracil

by Shrestha, Shikshya, Tapper, Erin E., Trogstad-Isaacson, Colbren (Scout), Hobday, Timothy J., Offer, Steven M., Diasio, Robert B.
Published in JCO Precis Oncol (2018)

Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma

by McGarrah, Patrick W., Leventakos, Konstantinos, Hobday, Timothy J., Molina, Julian R., Finnes, Heidi D., Westin, Gustavo F., Halfdanarson, Thorvardur R.
Published in Pancreas (2020)

Risk Factors for Pancreatic Neuroendocrine Tumors (PNETs): A Clinic-Based Case-Control study

by Halfdanarson, Thorvardur R., Bamlet, William R., McWilliams, Robert R, Hobday, Timothy J., Burch, Patrick A., Rabe, Kari G., Petersen, Gloria M.
Published in Pancreas (2014)

Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144

by Dy, Grace K., Hobday, Timothy J., Nelson, Garth, Windschitl, Harold E., O’Connell, Michael J., Alberts, Steven R., Goldberg, Richard M., Nikcevich, Daniel A., Sargent, Daniel J.
Published 2009

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

by Hobday, Timothy J., Qin, Rui, Reidy-Lagunes, Diane, Moore, Malcolm J., Strosberg, Jonathan, Kaubisch, Andreas, Shah, Manisha, Kindler, Hedy Lee, Lenz, Heinz-Josef, Chen, Helen, Erlichman, Charles
Published in J Clin Oncol (2015)

Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine Tumors

by Liu, Alex J., Ueberroth, Benjamin E., McGarrah, Patrick W., Buckner Petty, Skye A., Kendi, Ayse Tuba, Starr, Jason, Hobday, Timothy J., Halfdanarson, Thorvardur R., Sonbol, Mohamad Bassam
Published in Oncologist (2021)

Breast Medical Oncologists' Use of Standard Prognostic Factors to Predict a 21-Gene Recurrence Score

by Kamal, Arif H., Loprinzi, Charles L., Reynolds, Carol, Dueck, Amylou C., Geiger, Xochiquetzal J., Ingle, James N., Carlson, Robert W., Hobday, Timothy J., Winer, Eric P., Goetz, Matthew P.
Published 2011

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

by Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Published 2012

NCCTG N0543 (Alliance): A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma

by McWilliams, Robert R., Foster, Nathan R., Mahoney, Michelle R., Smyrk, Thomas C., Murray, Joseph A., Ames, Matthew M., Horvath, Elise, Schneider, Daniel, Hobday, Timothy J., Jatoi, Aminah, Meyers, Jeffrey P., Goetz, Matthew P.
Published in Cancer (2017)

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group (NCCTG) trials, N0...

by Reinholz, Monica M., Kitzmann, Kathleen A., Tenner, Kathleen, Hillman, David, Dueck, Amylou C., Hobday, Timothy J., Northfelt, Donald W., Moreno-Aspitia, Alvaro, Roy, Vivek, LaPlant, Betsy, Allred, Jake B., Stella, Philip J., Lingle, Wilma L., Perez, Edith A.
Published in Clin Cancer Res (2011)

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

by Kalli, Kimberly R., Block, Matthew S., Kasi, Pashtoon M., Erskine, Courtney L., Hobday, Timothy J., Dietz, Allan B., Padley, Douglas J., Gustafson, Michael P., Visscher, Dan W., Puglisi-Knutson, Danell J., Shreeder, Barath, Mangskau, Toni K., Wilson, Glynn, Knutson, Keith L.
Published in Clin Cancer Res (2018)

Rapid generation of sustainable HER2-specific T cell immunity in HER2 breast cancer patients using a degenerate HLA class II epitope vaccine

by Knutson, Keith L., Block, Matthew S., Norton, Nadine, Erskine, Courtney L., Hobday, Timothy J., Dietz, Allan B., Padley, Douglas J., Gustafson, Michael P., Puglisi-Knutson, Danell J., Mangskau, Toni K., Chumsri, Saranya, Dueck, Amylou C., Karyampudi, Lavakumar, Wilson, Glynn, Degnim, Amy
Published in Clin Cancer Res (2019)

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103)

by Miller, Kathy D., O’Neill, Anne, Gradishar, William, Hobday, Timothy J., Goldstein, Lori J., Mayer, Ingrid A., Bloom, Stuart, Brufsky, Adam M., Tevaarwerk, Amye J., Sparano, Joseph A., Le-Lindqwister, Nguyet Anh, Hendricks, Carolyn B., Northfelt, Donald W., Dang, Chau T., Sledge, George W.
Published in J Clin Oncol (2018)

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

by Kulke, Matthew H., Siu, Lillian L., Tepper, Joel E., Fisher, George, Jaffe, Deborah, Haller, Daniel G., Ellis, Lee M., Benedetti, Jacqueline K., Bergsland, Emily K., Hobday, Timothy J., Van Cutsem, Eric, Pingpank, James, Oberg, Kjell, Cohen, Steven J., Posner, Mitchell C., Yao, James C.
Published 2011

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

by Yao, James C., Shah, Manisha H., Ito, Tetsuhide, Bohas, Catherine Lombard, Wolin, Edward M., Van Cutsem, Eric, Hobday, Timothy J., Okusaka, Takuji, Capdevila, Jaume, de Vries, Elisabeth G.E., Tomassetti, Paola, Pavel, Marianne E., Hoosen, Sakina, Haas, Tomas, Lincy, Jeremie, Lebwohl, David, Öberg, Kjell
Published 2011

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

by Yao, James C., Lombard-Bohas, Catherine, Baudin, Eric, Kvols, Larry K., Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, St. Peter, Jessica, Haas, Tomas, Lebwohl, David, Van Cutsem, Eric, Kulke, Matthew H., Hobday, Timothy J., O'Dorisio, Thomas M., Shah, Manisha H., Cadiot, Guillaume, Luppi, Gabriele, Posey, James A., Wiedenmann, Bertram
Published in J Clin Oncol (2010)

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study

by Zirpoli, Gary R, McCann, Susan E, Sucheston-Campbell, Lara E, Hershman, Dawn L, Ciupak, Gregory, Davis, Warren, Unger, Joseph M, Moore, Halle C F, Stewart, James A, Isaacs, Claudine, Hobday, Timothy J, Salim, Muhammad, Hortobagyi, Gabriel N, Gralow, Julie R, Budd, G Thomas, Albain, Kathy S, Ambrosone, Christine B
Published in J Natl Cancer Inst (2017)